Podcast Episodes
Back to SearchFighting Alzheimer's with innovative stem cell therapies
Episode 139
Regeneration Biomedical has developed a new technique to address neurodegenerative diseases like Alzheimer's using stem cell therapy.
Dr. Christopher …
1 year, 7 months ago
[Rebroadcast] How AI immune system mapping can boost drug discovery
Episode 138
We’re taking a short break this week and, while we’re away, we invite you to enjoy one of our favorite episodes. We will return with a brand-new epis…
1 year, 7 months ago
The TCR-T cell therapies of tomorrow
Sweden's fastest growing private biotech, Anocca, is making plans for clinical trials in pancreatic cancer, with the TCR-T cell therapy trials called…
1 year, 7 months ago
Can RNA drugs solve the obesity epidemic?
Resalis Therapeutics is pursuing a groundbreaking approach to obesity treatment.
Unlike current therapies that primarily focus on appetite suppression…
1 year, 7 months ago
Reversing cancer mechanisms to fight back against solid tumors
CatalYm is preparing to initiate its broad phase 2b clinical development program for visugromab to tackle multiple solid tumor indications.
Visugroma…
1 year, 8 months ago
Targeting the dark genome to develop new therapies to fight obesity
In the fall of 2024, Haya Therapeutics, based in Switzerland and San Diego, landed a $1bn deal with Eli Lilly to apply its long non-coding RNA (ncRNA…
1 year, 8 months ago
Can Tumor Activated Therapy kill solid tumors?
Solid tumors present a big challenge for current treatments. However, a new approach might provide the answers - Tumor Activated Therapy.
By targetin…
1 year, 8 months ago
J.P. Morgan Annual Healthcare Conference 2025: trends and highlights you may have missed
This week, we take a look at some of the highlights from the 43rd Annual J.P. Morgan Healthcare Conference, which took place in San Francisco recentl…
1 year, 8 months ago
Venture capital co-creation: The next big thing in biotech investment?
Jessica Owens and Iana Dimkova are co-founders of Initiate Ventures—a female-led venture capital firm and studio that launched recently with a $45 mi…
1 year, 9 months ago
Developing non-opioid pain drugs
Brixton Biosciences, a clinical-stage life sciences company spun out from Massachusetts General Brigham, has been awarded $2m from the NIH HEAL Initi…
1 year, 9 months ago